Rate My Professor Patrick Loehrer

A leading medical oncologist, Loehrer specializes in testicular, bladder, colon, pancreatic, and thymic malignancies. His research advanced ifosfamide to FDA approval and earned the Exceptional Service Award from the Foundation for Thymic Research for thymic cancer studies. As founding chair of the Hoosier Oncology Group (now Hoosier Cancer Research Network) for two decades, he oversaw clinical trials enrolling over 5,000 patients in 20 countries. In global oncology, Loehrer founded the AMPATH-Oncology Program in western Kenya, treating over 8,000 cancer patients annually, screening over 1,500 women monthly for breast and cervical cancers, and serving as co-PI on a U54 NIH grant for HPV studies in East Africa. He chairs the National Cancer Institute Clinical Trials Advisory Committee, previously served on boards of the American Society of Clinical Oncology, ECOG Foundation, American Board of Internal Medicine, and American Association of Cancer Institutes, and delivered public lectures such as 'Thymoma: Current Status and Future Directions' in 2024. Major awards include the ASCO Humanitarian Award (2023), Allen S. Lichter Visionary Leader Award (2017), John W. Ryan Award (2026), Indiana University Bicentennial Medal, Purdue University Outstanding Mechanical Engineering Award, and Distinguished Engineering Alumni Award. His contributions encompass over 350 publications, including 'The Integrated Genomic Landscape of Thymic Epithelial Tumors' (2018) and 'Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer' (NEJM, 1998), with more than 26,900 citations.